News and Press Releases
Medications Study of Ivacaftor in Children Ages 1 to 2 Shows Positive Results

Positive results from a study of ivacaftor (Kalydeco®) in children ages 1 to 2 were announced today.

Dec. 7, 2017 | 2 min read
Medications Positive Results from Two Phase 3 Clinical Studies of Tezacaftor (VX-661) and Ivacaftor

Two Phase 3 clinical trials of tezacaftor (VX-661) in combination with ivacaftor (Kalydeco®) showed positive results, Vertex Pharmaceuticals announced today.

March 28, 2017 | 4 min read
About the CF Foundation | Medications Walgreens Completes Transaction to Gain Ownership Stake in Cystic Fibrosis Specialty Pharmacy

Update: On February 3, 2017, the Cystic Fibrosis Foundation divested its remaining ownership stake in CF Services Inc., a specialty pharmacy. The pharmacy is now fully owned by Walgreens.

Feb. 3, 2017 | 3 min read